Citation: Dw. Scheifele et al., Assessment of injection site reactions to an acellular pertussis-based combination vaccine, including novel use of skin tests with vaccine antigens, VACCINE, 19(32), 2001, pp. 4720-4726
Citation: Ad. Sadovnick et Dw. Scheifele, School-based hepatitis B vaccination programme and adolescent multiple sclerosis, LANCET, 355(9203), 2000, pp. 549-550
Authors:
Scheifele, DW
Skowronski, D
King, A
LaJeunesse, CA
Bjornson, GL
Parkyn, H
Walker, N
Stefura, E
Citation: Dw. Scheifele et al., Evaluation of ready-to-use and multi-dose influenza vaccine formats in large clinic settings, CAN J PUBL, 91(5), 2000, pp. 329-332
Citation: Dw. Scheifele et al., A comparative study of PENTA (TM) vaccine booster doses given at 12, 15 or18 months of age, VACCINE, 17(6), 1999, pp. 543-550
Authors:
Scheifele, DW
Halperin, SA
Guasparini, R
Meekison, W
Pim, C
Barreto, L
Citation: Dw. Scheifele et al., Extended follow-up of antibody levels and antigen responsiveness after 2 Haemophilus influenzae type b conjugate vaccines, J PEDIAT, 135(2), 1999, pp. 240-245
Authors:
Scheifele, DW
Dobson, S
Kallos, A
Bjornson, G
Ochnio, JJ
Citation: Dw. Scheifele et al., Comparative safety of tetanus-diphtheria toxoids booster immunization in students in Grades 6 and 9, PEDIAT INF, 17(12), 1998, pp. 1121-1126